{"id":10,"date":"2013-10-13T20:23:39","date_gmt":"2013-10-13T20:23:39","guid":{"rendered":"http:\/\/www.modestosurgery.com\/surgeryblog\/?p=10"},"modified":"2013-10-13T20:23:39","modified_gmt":"2013-10-13T20:23:39","slug":"what-is-octreotide","status":"publish","type":"post","link":"http:\/\/www.modestosurgery.com\/surgeryblog\/what-is-octreotide\/","title":{"rendered":"What is Octreotide"},"content":{"rendered":"<h2>Octreotide<\/h2>\n<ul>\n<li>Sandostatin is the brand name &#8211; by <a title=\"Norvatis\" href=\"http:\/\/www.us.novartis.com\/\">Novartis<\/a><\/li>\n<li>Mimics natural somatostatin pharmacologically<\/li>\n<li>But is more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin.<\/li>\n<li>May be considered a treatment in carcinoid syndrome.<\/li>\n<li>The prophylactic use of perioperative octreotide does not reduce the incidence of pancreatic fistula or complications after pancreaticoduodenectomy (Whipple). \u00a0Reference: \u00a0<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1421155\/\">http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1421155\/<\/a>\u00a0&#8211; article from the year 2000:\u00a0Does Prophylactic Octreotide Decrease the Rates of Pancreatic Fistula and Other Complications After Pancreaticoduodenectomy?<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Octreotide Sandostatin is the brand name &#8211; by Novartis Mimics natural somatostatin pharmacologically But is more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. May be considered a treatment in carcinoid syndrome. The prophylactic use of perioperative octreotide does not reduce the incidence of pancreatic fistula or complications after pancreaticoduodenectomy (Whipple). \u00a0Reference: \u00a0http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1421155\/\u00a0&#8211; &hellip; <a href=\"http:\/\/www.modestosurgery.com\/surgeryblog\/what-is-octreotide\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">What is Octreotide<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,13,14,17,15,18],"tags":[19],"class_list":["post-10","post","type-post","status-publish","format-standard","hentry","category-carcinoid-syndrome","category-octreotide","category-pancreatic-fistulas","category-prophylaxis","category-somatostatin","category-whipple","tag-norvatis"],"_links":{"self":[{"href":"http:\/\/www.modestosurgery.com\/surgeryblog\/wp-json\/wp\/v2\/posts\/10","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.modestosurgery.com\/surgeryblog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.modestosurgery.com\/surgeryblog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.modestosurgery.com\/surgeryblog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.modestosurgery.com\/surgeryblog\/wp-json\/wp\/v2\/comments?post=10"}],"version-history":[{"count":1,"href":"http:\/\/www.modestosurgery.com\/surgeryblog\/wp-json\/wp\/v2\/posts\/10\/revisions"}],"predecessor-version":[{"id":11,"href":"http:\/\/www.modestosurgery.com\/surgeryblog\/wp-json\/wp\/v2\/posts\/10\/revisions\/11"}],"wp:attachment":[{"href":"http:\/\/www.modestosurgery.com\/surgeryblog\/wp-json\/wp\/v2\/media?parent=10"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.modestosurgery.com\/surgeryblog\/wp-json\/wp\/v2\/categories?post=10"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.modestosurgery.com\/surgeryblog\/wp-json\/wp\/v2\/tags?post=10"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}